SCHEDULE 13G: John Fife and Fredrick Waid Disclose 9.9% Passive Stake in Jaguar Health, Inc.
Beneficial Ownership Disclosure
John Fife and Fredrick Waid have jointly disclosed a passive beneficial ownership of 9.9% in Jaguar Health, Inc., totaling 1,290,000 shares of common stock.
Summary
- John Fife and Fredrick Waid, both U.S. citizens, have filed a Schedule 13G indicating beneficial ownership in Jaguar Health, Inc.
- The aggregate amount beneficially owned by the reporting persons is 1,290,000 shares of common stock.
- This ownership represents 9.9% of Jaguar Health, Inc.'s outstanding common stock, based on 13,088,288 shares outstanding.
- John Fife holds sole voting and dispositive power over all 1,290,000 shares.
- The shares are held through a multi-layered structure: 1,290,000 shares are issued in the name of Uptown Capital, LLC, which is wholly-owned by Andersonville Capital, LLC.
- Andersonville Capital, LLC is 99% beneficially owned by the Van Sicklen Road Trust, managed by Fredrick Waid as trustee, and 1% beneficially owned by John M. Fife.
- Despite the complex structure, John M. Fife retains sole voting power over Andersonville Capital, LLC.
- The filing certifies that the securities were not acquired and are not held for the purpose or effect of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual regulatory disclosure of beneficial ownership and does not convey positive or negative sentiment regarding the company's performance or prospects. It is neutral in tone and content.
Positives
- The disclosure indicates a significant, albeit passive, stake by investors, which can be viewed as a vote of confidence in the company's long-term prospects.
- The filing explicitly states that the ownership is not for the purpose of changing or influencing control, suggesting a stable shareholder base.
Risks
- While the filing states the ownership is passive, a large concentration of shares in a few hands could potentially influence future corporate actions, even without an explicit intent to control.
Future Outlook
This Schedule 13G filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This filing is a standard regulatory disclosure of significant passive ownership and does not provide specific insights into broader industry trends or competitive dynamics within the pharmaceutical or healthcare sector. It primarily reflects an investment decision by specific individuals/entities.
Stakeholder Impact
- Shareholders: The disclosure of a significant passive stake by John Fife and Fredrick Waid may provide a degree of confidence, indicating that experienced investors see value in Jaguar Health, Inc.
Key Dates
| Date | Description |
|---|---|
| 01/29/2025 | Date of event which requires filing of this statement and signature date of the filing. |
Keywords
Jaguar Health Inc., Beneficial Ownership, Schedule 13G, Common Stock, John Fife, Fredrick Waid, Uptown Capital, Andersonville Capital, SEC Filing, Shareholder Disclosure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.